MICHAEL G ATIEH Insider Trading $OSIP OSI PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL G ATIEH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL G ATIEH. MICHAEL G ATIEH is Exec. VP & CFO in OSI PHARMACEUTICALS INC ($OSIP).
MICHAEL G ATIEH in OSI PHARMACEUTICALS INC
Trading Symbol: OSIPIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of MICHAEL G ATIEH: Exec. VP & CFO
Holdings: 31,897 shares
Latest Transaction: Dec 16 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MICHAEL G ATIEH in OSI PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 16 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Payment of Exercise | F | 33.39 | 550 | 18,365 | 31,897 | 32.4 K to 31.9 K (-1.70 %) |
Dec 16 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Payment of Exercise | F | 33.39 | 880 | 29,383 | 32,447 | 33.3 K to 32.4 K (-2.64 %) |
Nov 21 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 39.11 | 10,000 | 391,100 | 33,327 | 43.3 K to 33.3 K (-23.08 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Option Exercise | M | 30.74 | 50,000 | 1,537,000 | 0 | |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.00 | 23,753 | 1,211,403 | 43,327 | 67.1 K to 43.3 K (-35.41 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.01 | 5,254 | 268,007 | 67,080 | 72.3 K to 67.1 K (-7.26 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.04 | 1,800 | 91,872 | 72,334 | 74.1 K to 72.3 K (-2.43 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.03 | 1,400 | 71,442 | 74,134 | 75.5 K to 74.1 K (-1.85 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.02 | 600 | 30,612 | 75,534 | 76.1 K to 75.5 K (-0.79 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.05 | 1,621 | 82,752 | 76,134 | 77.8 K to 76.1 K (-2.08 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.07 | 800 | 40,856 | 77,755 | 78.6 K to 77.8 K (-1.02 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.10 | 3,272 | 167,199 | 78,555 | 81.8 K to 78.6 K (-4.00 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.12 | 5,200 | 265,824 | 81,827 | 87 K to 81.8 K (-5.98 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.13 | 479 | 24,491 | 87,027 | 87.5 K to 87 K (-0.55 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.11 | 900 | 45,999 | 87,506 | 88.4 K to 87.5 K (-1.02 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.20 | 32 | 1,638 | 88,406 | 88.4 K to 88.4 K (-0.04 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.18 | 1,000 | 51,180 | 88,438 | 89.4 K to 88.4 K (-1.12 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.16 | 1,468 | 75,103 | 89,438 | 90.9 K to 89.4 K (-1.61 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.17 | 200 | 10,234 | 90,906 | 91.1 K to 90.9 K (-0.22 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.22 | 100 | 5,122 | 91,106 | 91.2 K to 91.1 K (-0.11 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.09 | 1,421 | 72,599 | 91,206 | 92.6 K to 91.2 K (-1.53 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.06 | 100 | 5,106 | 92,627 | 92.7 K to 92.6 K (-0.11 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.08 | 600 | 30,648 | 92,727 | 93.3 K to 92.7 K (-0.64 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Buy | M | 30.74 | 50,000 | 1,537,000 | 93,327 | 43.3 K to 93.3 K (+115.40 %) |
Jul 16 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Payment of Exercise | F | 44.72 | 633 | 28,308 | 43,327 | 44 K to 43.3 K (-1.44 %) |
Jun 12 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 39.64 | 1,866 | 73,968 | 43,960 | 45.8 K to 44 K (-4.07 %) |
Jun 05 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Payment of Exercise | F | 35.30 | 1,134 | 40,030 | 45,826 | 47 K to 45.8 K (-2.41 %) |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Option Exercise | A | 47.29 | 24,000 | 1,134,960 | 24,000 | |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Payment of Exercise | F | 47.79 | 475 | 22,700 | 46,960 | 47.4 K to 47 K (-1.00 %) |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Grant | A | 0.00 | 8,040 | 0 | 47,435 | 39.4 K to 47.4 K (+20.41 %) |
Jul 18 2007 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Payment of Exercise | F | 33.71 | 641 | 21,608 | 39,395 | 40 K to 39.4 K (-1.60 %) |
Dec 15 2006 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Option Exercise | A | 37.74 | 15,000 | 566,100 | 15,000 | |
Dec 15 2006 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Grant | A | 0.00 | 5,025 | 0 | 40,036 | 35 K to 40 K (+14.35 %) |
Jul 18 2006 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Grant | A | 0.00 | 6,700 | 0 | 35,011 | 28.3 K to 35 K (+23.67 %) |
Jun 15 2006 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Option Exercise | A | 29.77 | 20,000 | 595,400 | 20,000 |
Page: 1